Cargando…

Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass

BACKGROUND AND OBJECTIVES: To explore the lung-protective effect of levosimendan (LS) during cardiopulmonary bypass in a canine model by determining the wet/dry weight (W/D) ratio of lung tissue, malonaldehyde (MDA) and superoxide dismutase (SOD) concentrations, and performing a histological evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Junbo, Liu, Haiyuan, Chen, Jiayi, Wang, Jiyuan, Liu, Zhuang, Ge, Shenglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891605/ https://www.ncbi.nlm.nih.gov/pubmed/27275177 http://dx.doi.org/10.4070/kcj.2016.46.3.402

Ejemplares similares

Influence of Levosimendan Postconditioning on Apoptosis of Rat Lung Cells in a Model of Ischemia–Reperfusion Injury
por: Zhang, Chengxin, et al.
Publicado: (2015)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)

Ultrafiltration attenuates cardiopulmonary bypass–induced acute lung injury in a canine model of single-lung transplantation
por: Saitoh, Masayuki, et al.
Publicado: (2006)

A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass
por: Salgado Filho, Marcello Fonseca, et al.
Publicado: (2015)

Endothelial colony-forming cells reduced the lung injury induced by cardiopulmonary bypass in rats
por: Sun, Haibin, et al.
Publicado: (2020)

Effects of levosimendan started 24 hours before cardiopulmonary bypass in patients admitted to the ICU with an ejection fraction lower than 30%
por: Duchateau, J, et al.
Publicado: (2009)

Levosimendan in rats decreases acute kidney injury after cardiopulmonary resuscitation by improving mitochondrial dysfunction
por: Zhao, Li, et al.
Publicado: (2021)

The altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury
por: Qin, Han, et al.
Publicado: (2013)

Correction to: Endothelial colony-forming cells reduced the lung injury induced by cardiopulmonary bypass in rats
por: Sun, Haibin, et al.
Publicado: (2021)

Strategies to prevent intraoperative lung injury during cardiopulmonary bypass
por: Apostolakis, Efstratios E, et al.
Publicado: (2010)

Biomarkers for Adverse Lung Injury Following Pediatric Cardiopulmonary Bypass
por: Asfari, Ahmed, et al.
Publicado: (2021)

Lung injury after cardiopulmonary bypass: Alternative treatment prospects
por: Zheng, Xue-Mei, et al.
Publicado: (2022)

Levosimendan Ameliorates Cardiopulmonary Function but Not Inflammatory Response in a Dual Model of Experimental ARDS
por: Rissel, René, et al.
Publicado: (2022)

Pulmonary perfusion reduces accumulation of neutrophils in the lung during cardiopulmonary bypass
por: Schlensak, C, et al.
Publicado: (2003)

Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model
por: Huang, Xiaolin, et al.
Publicado: (2021)

Infusion of sodium sulfide improves myocardial and endothelial function in a canine model of cardiopulmonary bypass
por: Szabó, C, et al.
Publicado: (2007)

N-acetylcysteine attenuates cardiopulmonary bypass-induced lung injury in dogs
por: Qu, Xianfeng, et al.
Publicado: (2013)

Remote ischemic preconditioning attenuates cardiopulmonary bypass-induced lung injury
por: Zhou, Xiaona, et al.
Publicado: (2017)

The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia
por: Schwarte, Lothar A., et al.
Publicado: (2011)

The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Pan, Tuo, et al.
Publicado: (2023)

Inhibition of Pre-B Cell Colony Enhancing Factor Reduces Lung Injury in Rats Receiving Cardiopulmonary Bypass
por: Lu, Chao, et al.
Publicado: (2021)

Cardiopulmonary Bypass
por: Rondelez, Luc, et al.
Publicado: (2010)

Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass
por: Salameh, Aida, et al.
Publicado: (2020)

Effects of Erythropoietin on Lung Injury Induced by Cardiopulmonary Bypass After Cardiac Surgery
por: Lin, Xue, et al.
Publicado: (2020)

Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Pan, Tuo, et al.
Publicado: (2023)

Cardiac operation under cardiopulmonary bypass during pregnancy
por: Liu, Yanli, et al.
Publicado: (2020)

A simple technique can reduce cardiopulmonary bypass use during lung transplantation
por: Samano, Marcos N, et al.
Publicado: (2016)

Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)
por: Caruba, Thibaut, et al.
Publicado: (2016)

Pretreatment with levosimendan improves outcome in off-pump coronary artery bypass grafting
por: Husedzinovic, I, et al.
Publicado: (2013)

Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery
por: Sahu, Manoj K., et al.
Publicado: (2016)

Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury
por: Roehl, Anna B, et al.
Publicado: (2010)

Acute Kidney Injury following Cardiopulmonary Bypass: A Challenging Picture
por: Liu, Dianxiao, et al.
Publicado: (2021)

Effects of inosine on reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2010)

Acute kidney injury following cardiopulmonary bypass in Jamaica
por: Fisher, Lori-Ann, et al.
Publicado: (2022)

Anti-apoptosis effect of heme oxygenase-1 on lung injury after cardiopulmonary bypass
por: Sheng, Wei, et al.
Publicado: (2020)

Basics of cardiopulmonary bypass
por: Sarkar, Manjula, et al.
Publicado: (2017)

Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2015)

Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury
por: Kandler, Kristian, et al.
Publicado: (2019)

NO Addition during Gas Oxygenation Reduces Liver and Kidney Injury during Prolonged Cardiopulmonary Bypass
por: Radovskiy, Aleksey Maksimovich, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m6ql0v12aai1nvg0fn0531muvc